Principios de las pruebas de vacunas contra la malaria: Memorandum de una reunion de la OMS
Date
s.d.1988
Document Number
TDR/IMMAL-FIELDMAL/VAC/85
Metadata
Show full item recordAbstract
Despite the considerable advances recently achieved in malaria control, the disease has remained a major public health problem in many tropical and sub-tropical countries. The development of vaccines against malaria has progressed rapidly over the past few years, and it is expected that they will play an important role in controlling the disease in the not-too-distant future. This Memorandum presents the strategies recommended by the World Health Organization for the performance of malaria vaccine trials. Malaria vaccines will be based on pure parasite antigens which specifically stimulate protective immune responses. In view of the life cycle of the Plasmodium, the three types of vaccine now being developed target sporozoites, asexual erythrocytic stages, and gametes. Each vaccine would confer specific immunity and its application would thus be directed at different population groups according to their epidemiological situation. A sporozoite vaccine, if fully effective, would prevent plasmodial development in the host. A vaccine of this type should be able to interrupt the natural transmission of malaria, although a given subject would show clinical illness if transfused with infected blood since he/she would not be immune to the asexual erythrocytic forms. An asexual erythrocytic-stage vaccine would restrict the replication of these forms, but would not induce sterile immunity
Translated title
Principles of malaria vaccine trials: Memorandum from WHO meeting
Subject
Collections
Related items
Showing items related by title, author, creator and subject.
-
Pan American Health Organization; Family, Health Promotion and Life Course (FPL) (PAHOUnited StatesWashington, D.C., 2022)One of the essential components of the safe vaccination system is the surveillance of events supposedly attributable to vaccination or immunization (ESAVI). This surveillance is aimed at early detection of any adverse ...
-
Pinkney, Jodian A.; Carroll, Kamali N.; Rich, Katherine M.; Hurtado, Rocio M.; Ciaranello, Andrea L.; Bogart, Laura M.; Ojikutu, Bisola O.; Hyle, Emily P. (2023)[ABSTRACT]. Pregnant people with coronavirus disease 2019 (COVID-19) have a higher risk of adverse maternal and fetal outcomes compared with pregnant people without COVID-19. In 2021, large increases in maternal mortality ...
-
Pan American Health Organization; Family, Health Promotion and Life Course (FPL) (PAHOUnited StatesWashington, D.C., 2021)With the World Health Organization (WHO) currently developing the Global Immunization Vision and Strategy 2030, this publication reports on the progress made in implementing the Plan of Action on Immunization for the Region ...